Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Henan Sinotech Biotechnology

Request full access

A joint-stock company approved by the provincial government in the animal husbandry industry

ChinaFounded 2010Biotech & Life Sciences

About Henan Sinotech Biotechnology

Celnovte Biotechnology Co., Ltd., established in 2010, operates as a specialized developer and manufacturer of pathological diagnostic reagents and instruments. The company is headquartered in Zhengzhou, China, with a global structure that includes a reagent and instrument development center in Rockville, MD, USA, an instrument R&D subsidiary in Shenzhen, a research-use product development arm in Suzhou, and manufacturing facilities in Zhengzhou.

The company's business model is centered on the development, production, and distribution of a comprehensive portfolio for the in-vitro diagnostics (IVD) market, with a focus on oncology pathology. Revenue is generated through the sale of its products to a client base that includes over 2,300 hospitals in China and a distribution network spanning more than 40 countries. Celnovte also engages in OEM/ODM partnerships, offering customized solutions and leveraging its more than 10 years of experience in pathology instrument design.

Celnovte's product offerings are extensive, covering immunohistochemistry (IHC), in-situ hybridization (ISH), histology, molecular diagnostics, cytology, and digital pathology. Key technologies include the MicroStacker™ IHC detection system, known for its high sensitivity and specificity, and the PolyStacker™ technology, which significantly reduces the turnaround time for frozen section IHC experiments to as little as 10 minutes. Additionally, its SuperISH™ RNA in-situ hybridization technology allows for RNA target detection at a single-molecule level. The company also manufactures fully automated instrumentation, such as IHC stainers, H&E stainers, special stainers, and digital slide scanners. A notable achievement has been the installation of over 800 automated IHC stainers worldwide since their launch in 2018.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
China
Employees
19
Open positions
None listed
Dealroom signal
53.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Nov 2022 $14M $55M Puhua Capital · Henan Gaochuang · Henan Zhongyuan Lianchuang Investment Fund Management · Gaoxin Industrial Investment ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Henan Sinotech Biotechnology website traffic

Latest recorded traffic for Henan Sinotech Biotechnology is 700 monthly website visits, up 311.8% over the last three months. Henan Sinotech Biotechnology's team grew 35.7% over the past year.

Latest monthly visits700 3-month web change+311.8% 1-year team growth+35.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Henan Sinotech Biotechnology in its local ecosystem

Live from Dealroom

The Henan Sinotech Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Puhua Capital
  • Henan Gaochuang
  • Henan Zhongyuan Lianchuang Investment Fund Management
  • Gaoxin Industrial Investment
Employees 19 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States54.5%
🇨🇳 China27.3%
🇧🇷 Brazil9.1%
🇹🇷 Turkey9.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Henan Sinotech Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Henan Sinotech Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.